Corcept Therapeutics
Get verified emails for Corcept Therapeutics employeesAbout Corcept Therapeutics
Corcept Therapeutics is a biotechnology company focused on cortisol modulation. Short and direct, that is the core of its work. It researches and develops cortisol modulators, molecules that regulate cortisol activity at the glucocorticoid receptor (GR), and has discovered more than 1,000 selective proprietary cortisol modulators.
FDA approval came in 2012 for a cortisol receptor blocker and the first approved treatment for hypercortisolism (Cushing’s syndrome). That was a major step for the company. It is also conducting more than 30 ongoing studies across endocrinology, oncology, metabolism, and neurology.
Founded in 1998 and based in Redwood, California, Corcept Therapeutics has a team size of 501-1000. Small team, broad scope. It continues to work with collaborators on applications of cortisol modulation in serious diseases.
Need to reach the Corcept Therapeutics team directly? Find verified work emails for every employee with Snov.io
Insights
Updated 27 Aug 2026Corcept Therapeutics operates in a Cushing syndrome market that is becoming more crowded. DelveInsight says more than 5 companies and more than 5 pipeline drugs are active in the space, which points to a field defined by a growing clinical pipeline rather than a single-company niche.
That pipeline coverage spans both clinical and nonclinical-stage products. In practical terms, this means development is still moving across the category, and Corcept is working in a setting where ongoing R&D may increase pressure to stand out on efficacy, safety, or trial progress as more programs advance.
Investor sentiment looks constructive. Two separate reports say OMERS Administration Corp and Odyssean LLC opened new positions in Corcept Therapeutics during the second quarter, with reported stakes valued at approximately $2.669 million and $1.241 million, respectively, which suggests institutional interest in the stock despite the broader competitive backdrop.
Frequently asked questions
Corcept Therapeutics is headquartered in Redwood, California, United States.
Corcept Therapeutics has 501-1000 employees according to its company profile.
Corcept Therapeutics operates in the Biotechnology sector. Public valuation figures are not always disclosed for private companies.